...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ... just for whatever reason...

Hi Tada, 

What makes you think we will be listed on a major exchange in the next few months? Are you referring to a TSX venture listing or an Nasdaq IPO? Unless we have a major partnership with a BP how will get any retail investor interest,  i hope your right but seems unlikely at this point 

 

Share
New Message
Please login to post a reply